Literature DB >> 7204686

Benzoyl peroxide: percutaneous penetration and metabolic disposition.

S Nacht, D Yeung, J N Beasley, M D Anjo, H I Maibach.   

Abstract

The transepidermal penetration and metabolic disposition of 14C-benzoyl peroxide were assessed in vitro (excised human skin) and in vivo (rhesus monkey). In vitro, the benzoyl peroxide penetrated into the skin, through the stratum corneum or the follicular openings, or both, and was recovered on the dermal side as benzoic acid. In vivo, benzoic acid was recovered from urine in amounts equivalent to 45% and 98% of the radiolabel following, respectively, topical and intramuscular administration of small amounts of 14C-benzoyl peroxide. We conclude that benzoyl peroxide penetrates as such into the skin layers and is converted therein to benzoic acid, which, in turn is absorbed into the systemic circulation. Renal clearance of the metabolite is sufficiently rapid as to preclude its hepatic conjugation with glycine, since following topical administration to rhesus monkeys, no hippuric acid was found in the urine, as could have been expected had a significant amount of benzoic acid passed through the liver.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7204686     DOI: 10.1016/s0190-9622(81)70004-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  In vitro percutaneous absorption of benzoyl peroxide from three fixed combination acne formulations.

Authors:  Joshua A Zeichner; Varsha Bhatt; Radhakrishnan Pillai
Journal:  J Clin Aesthet Dermatol       Date:  2013-08

2.  The bioavailability of dermatological and other topically administered drugs.

Authors:  R H Guy; A H Guy; H I Maibach; V P Shah
Journal:  Pharm Res       Date:  1986-10       Impact factor: 4.200

Review 3.  Current views on the aetiology, pathogenesis and treatment of acne vulgaris.

Authors:  L Lever; R Marks
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

4.  [Acne therapy in pregnancy].

Authors:  C Bayerl
Journal:  Hautarzt       Date:  2013-04       Impact factor: 0.751

5.  Safety of skin care products during pregnancy.

Authors:  Pina Bozzo; Angela Chua-Gocheco; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2011-06       Impact factor: 3.275

Review 6.  Acne. A review of optimum treatment.

Authors:  N L Sykes; G F Webster
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.